JP Morgan initiated coverage on Blueprint Medicines Corporation (NASDAQ:BPMC), a biotech company focused on modulating immune mast cells. In 2023, the FDA approved Blueprint Medicines’ Ayvakit ...

Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug Nuvectis Pharma, Inc. (NASDAQ: NVCT) stock is trading lower after the company reported ...

(Reuters) - Chinese autonomous driving firm Pony AI said on Thursday it was targeting a valuation of up to $4.48 billion in its initial public offering in the United States. Pony, backed by Japanese ...

Federal Reserve Chair Jay Powell said the central bank does not need to be "in a hurry" to lower interest rates due to the economy’s strength, and that the Fed would be "watching carefully" to make ...

WASHINGTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious ...